On the enigma of pain and hyperalgesia: A molecular perspective

Biochemical and Biophysical Research Communications

Volumn 353, Issue 2, 2007, Pages 217-224

  Haddad, John J ^a,b  

^a Division of Biological Sciences   (Lebanon)

^b UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

Hyperalgesia; Inflammation; Nociception; Pain

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; AUTACOID; BRADYKININ RECEPTOR; CYCLOOXYGENASE 2; DEXAMETHASONE; GALANIN RECEPTOR; GAMMA MANGOSTIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KALLIDIN RECEPTOR; MELOXICAM; MORPHINE; PLANT EXTRACT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PYRROLIDINE DITHIOCARBAMATE; RECEPTOR; SALICYLATE SODIUM; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CORONARY ARTERY OBSTRUCTION; DEREGULATION; FEEDBACK SYSTEM; HEART INFARCTION PREVENTION; HEART PROTECTION; HOMEOSTASIS; HUMAN; HYPERALGESIA; INFLAMMATION; INFLAMMATORY PAIN; INJURY; MEDIATOR RELEASE; MOLECULAR BIOLOGY; NERVOUS SYSTEM INJURY; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAW EDEMA; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESTENOSIS; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; HUMANS; HYPERALGESIA; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, IMMUNOLOGICAL; NF-KAPPA B; PAIN;

EID: 33845906082     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.032     Document Type: Short Survey

References (56)

1. Wall P.D. Pain and animals. Nature 316 (1985) 672
2. Wall P.D. The mechanisms by which tissue damage and pain are related. Pain Mechanisms and Management 1 (1998) 252-259
3. Basbaum A.I., and Jessell T.M. The perception of pain. Principles of Neural Science 4 (2000) 473-491
4. Block B.M., Hurley R.W., and Raja S.N. Mechanism-based therapies for pain. Drug News Perspect. 17 (2004) 172-186
5. Saadé N.E., Massaad C.A., Kanaan S.A., Safieh-Garabedian B., Jabbur S.J., and Atweh S.F. Pain and neurogenic inflammation: A neural substrate for neuroendocrine-immune interactions. Pain and Neuroimmune Interactions 1 (2000) 111-123
6. Sung Y.J., and Ambron R.T. Pathways that elicit long-term changes in gene expression in nociceptive neurons following nerve injury: contributions to neuropathic pain. Neurol. Res. 26 (2004) 195-203
7. Isomura I., and Morita A. Regulation of NF-kB signaling by decoy oligodeoxynucleotides. Microbiol. Immunol. 50 (2006) 559-563
8. Park G.Y., and Christman J.W. Nuclear factor kB is a promising therapeutic target in inflammatory lung disease. Curr. Drug Targets 7 (2006) 661-668
9. Zhang J.H., and Huang Y.G. The immune system: a new look at pain. Chin. Med. J. (Engl.) 119 (2006) 930-938
10. Tegeder I., Niederberger E., Schmidt R., Kunz S., Guhring H., Ritzeler O., Michaelis M., and Geisslinger G. Specific Inhibition of IkB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J. Neurosci. 24 (2004) 1637-1645
11. Baliki M., Al-Amin H.A., Atweh S.F., Jaber M., Hawwa N., Jabbur S.J., Apkarian A.V., and Saadé N.E. Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat. Neuroscience 120 (2003) 1093-1104
12. Almeida T.F., Roizenblatt S., and Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res. 1000 (2004) 40-56
13. Woolf C.J. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci. 74 (2004) 2605-2610
14. Cervero F., and Laird J.M.A. One pain or many pains - A new look at pain mechanisms. News Physiologic. Sci. 6 (1991) 268-273
15. Zimmermann M., and Herdegen T. Plasticity of the nervous system at the systemic, cellular and molecular levels: a mechanism of chronic pain and hyperalgesia. Progress in Brain Research 110 (1996) 233-259
16. Poole S., Cunha F.Q., and Ferreira S.H. Bradykinin, cytokines and inflammatory hyperalgesia. Pain and Neuroimmune Interactions 1 (2000) 31-54
17. Massaad C.A., Safieh-Garabedian B., Poole S., Atweh S.F., Jabbur S.J., and Saadé N.E. Involvement of substance P, CGRP and histamine in the hyperalgesia and cytokine upregulation induced by intraplantar injection of capsaicin in rats. J. Neuroimmunol. 153 (2004) 171-182
18. Basbaum A.I., and Levine J.D. The contribution of the nervous system to inflammation and inflammatory disease. Can. J. Physiol. Pharmacol. 69 (1991) 647-651
19. Safieh-Garabedian B., Poole S., Haddad J.J., Massaad C.A., Jabbur S.J., and Saadé N.E. The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology 42 (2002) 864-872
20. Dray A. Tasting the inflammatory soup: The role of peripheral neurones. Pain Rev. 1 (1994) 153-171
21. McMahon S.B., and Koltzenburg M. The changing role of primary afferent neurons in pain. Pain 43 (1990) 269-272
22. Coderre T.J., Kats J., Vaccarino A., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
23. Dib-Hajj S.D., Fjell J., Cummins T.R., Zheng Z., Fried K., LaMotte R.H., Black J.A., and Waxman S.G. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 83 (1999) 591-600
24. Devor M., and Wall P.D. Cross-excitation in dorsal root ganglia of nerve - injured and intact rats. J. Neurophysiol. 64 (1990) 1733-1746
25. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6 (2005) 521-532
26. Chacur M., Milligan E.D., Gazda L.S., Armstrong C., Wang H., Tracey K.J., Maier S.F., and Watkins L.R. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 94 (2001) 231-244
27. Saadé N.E., Massaad C.A., Ochoa-Chaar C.I., Jabbur S.J., Safieh-Garabedian B., and Atweh S.F. Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin. J. Physiol. 545 (2002) 241-253
28. Jabbur S.J., and Saadé N.E. From electrical wiring to plastic neurons: evolving approaches to the study of pain. Pain 6 (1999) S87-S92
29. Safieh-Garabedian B., Haddad J.J., and Saadé N.E. Cytokines in the central nervous system: Targets for therapeutic intervention. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 271-280
30. Lee K.M., Kang B.S., Lee H.L., Son S.J., Hwang S.H., Kim D.S., Park J.S., and Cho H.J. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur. J. Neurosci. 19 (2004) 3375-3381
31. Meffert M.K., and Baltimore D. Physiological functions for brain NF-kB. Trends Neurosci. 28 (2005) 37-43
32. Ichiyama T., Sakai T., Catania A., Barsh G.S., Furukawa S., and Lipton J.M. Inhibition of peripheral NF-kB activation by central action of a-melanocyte-stimulating hormone. J. Neuroimmunol. 99 (1999) 211-217
33. Nadjar A., Tridon V., May M.J., Ghosh S., Dantzer R., Amedee T., and Parnet P. NF-kB activates in vivo the synthesis of inducible Cox-2 in the brain. J. Cereb. Blood Flow Metab. 25 (2005) 1047-1059
34. Haddad J.J., Olver R.E., and Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1a and NF-kB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem. 275 (2000) 21130-21139
35. La Rosa G., Cardali S., Genovese T., Conti A., Di Paola R., La Torre D., Cacciola F., and Cuzzocrea S. Inhibition of the nuclear factor-kB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J. Neurosurg. Spine 1 (2004) 311-321
36. Nakatani K., Yamakuni T., Kondo N., Arakawa T., Oosawa K., Shimura S., Inoue H., and Ohizumi Y. g-Mangostin inhibits inhibitor-kB kinase activity and decreases lipopolysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma cells. Mol. Pharmacol. 66 (2004) 667-674
37. Mitchell J.A., Saunders M., Barnes P.J., Newton R., and Belvisi M.G. Mol. Pharmacol. 51 (1997) 907-912
38. Vane J.R., and Botting R.M. The mechanism of action of aspirin. Thromb. Res. 110 (2003) 255-258
39. Mogil J.S., and McCarson K.E. Identifying pain genes: bottom-up and top-down approaches. J. Pain 1 (2000) 66-80
40. Lorimer D.D., Matkowskj K., and Benya R.V. Cloning, chromosomal location, and transcriptional regulation of the human galanin-1 receptor gene (GALN1R). Biochem. Biophys. Res. Commun. 241 (1997) 558-564
41. Dray A. Kinins and their receptors in hyperalgesia. Can. J. Physiol. Pharmacol. 75 (1997) 704-712
42. Calixto J.B., Medeiros R., Fernandes E.S., Ferreira J., Cabrini D.A., and Campos M.M. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 143 (2004) 803-818
43. Cabrini D.A., Campos M.M., Tratsk K.S., Merino V.F., Silva Jr. J.A., Souza G.E., Avellar M.C., Pesquero J.B., and Calixto J.B. Molecular and pharmacological evidence for modulation of kinin B1 receptor expression by endogenous glucocorticoids hormones in rats. Br. J. Pharmacol. 132 (2001) 567-577
44. Sakaue G., Shimaoka M., Fukuoka T., Hiroi T., Inoue T., Hashimoto N., Sakaguchi T., Sawa Y., Morishita R., Kiyono H., Noguchi K., and Mashimo T. NF-kB decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 12 (2001) 2079-2084
45. Jun-Ichi S., Hiroshi I., Ryo G., Ryuichi M., Kensuke E., and Mitsuaki I. Initial clinical cases of the use of a NF-kB decoy at the site of coronary stenting for the prevention of restenosis. Circ. J. 68 (2004) 270-271
46. Alam S.E., Nasser S.S., Fernainy K.E., Habib A.A., and Badr K.F. Cytokine imbalance in acute coronary syndrome. Curr. Opin. Pharmacol. 4 (2004) 166-170
47. Igwe O.J. Modulation of peripheral inflammation in sensory ganglia by nuclear factor kB decoy oligodeoxynucleotide: involvement of SRC kinase pathway. Neurosci. Lett. 381 (2005) 114-119
48. Yu C.G., and Yezierski R.P. Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury. Brain Res. Mol. Brain Res. 138 (2005) 244-255
49. Park H.J., Lee H.S., Lee H.J., Yoo Y.M., Lee H.J., Kim S.A., Leem K., Kim H.C., Seo J.C., Kim E.H., Lim S., and Chung J.H. Decrease of the electroacupuncture-induced analgesic effects in nuclear factor-kB1 knockout mice. Neurosci. Lett. 319 (2002) 141-144
50. Kraus J., Borner C., Giannini E., and Hollt V. The role of NF-kB in tumor necrosis factor-regulated transcription of the human m-opioid receptor gene. Mol. Pharmacol. 64 (2003) 876-884
51. DeLeo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10 (2004) 40-52
52. Borner C., Hollt V., and Kraus J. Involvement of activator protein-1 in transcriptional regulation of the human m-opioid receptor gene. Mol. Pharmacol. 61 (2002) 800-805
53. Bierhaus A., Haslbeck K.M., Humpert P.M., Liliensiek B., Dehmer T., Morcos M., Sayed A.A., Andrassy M., Schiekofer S., Schneider J.G., Schulz J.B., Heuss D., Neundorfer B., Dierl S., Huber J., Tritschler H., Schmidt A.M., Schwaninger M., Haering H.U., Schleicher E., Kasper M., Stern D.M., Arnold B., and Nawroth P.P. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J. Clin. Invest. 114 (2004) 1741-1751
54. Kim I.T., Park H.J., Nam J.H., Park Y.M., Won J.H., Choi J., Choe B.K., and Lee K.T. In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis. J. Pharm. Pharmacol. 57 (2005) 607-615
55. Frassdorf J., Weber N.C., Obal D., Toma O., Mullenheim J., Kojda G., Preckel B., and Schlack W. Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kB. Anesth. Analg. 101 (2005) 934-941
56. Haddad J.J., and Harb H.L. L-g-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?. Mol. Immunol. 42 (2005) 987-1014